These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35931918)

  • 1. Delayed kinetics of SARS-CoV-2 IgG antibody production in kidney transplant recipients following the third dose of COVID-19 vaccination.
    Matsunami M; Suzuki T; Yashima J; Kuji H; Matsue K
    Clin Exp Nephrol; 2023 Jan; 27(1):98-99. PubMed ID: 35931918
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of Humoral Response in Kidney Transplant Recipients and Donors and Healthy Volunteers Following Second Dose of SARS-CoV-2 mRNA Vaccine.
    Sasaki H; Hasegawa K; Harada H; Takamoto D; Takada Y; Hirano T; Tanabe T; Tanaka H; Miura M
    Transplant Proc; 2023 Apr; 55(3):514-520. PubMed ID: 36948961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Should We Consider Intradermal Vaccination?
    Wijtvliet V; Wissing KM; Abramowicz D; Ledeganck KJ
    J Am Soc Nephrol; 2022 Apr; 33(4):869-870. PubMed ID: 35165123
    [No Abstract]   [Full Text] [Related]  

  • 4. Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.
    Biagio P; Rosa C; Nicola SM; Fabrizio S; Amerigo P; Giulia Z; Riccardo S; Riccardo V; Paolo R; Lorenzo S; Ivan G; Federico Ii Covid Team
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
    Reindl-Schwaighofer R; Heinzel A; Mayrdorfer M; Jabbour R; Hofbauer TM; Merrelaar A; Eder M; Regele F; Doberer K; Spechtl P; Aschauer C; Koblischke M; Paschen C; Eskandary F; Hu K; Öhler B; Bhandal A; Kleibenböck S; Jagoditsch RI; Reiskopf B; Heger F; Bond G; Böhmig GA; Strassl R; Weseslindtner L; Indra A; Aberle JH; Binder M; Oberbauer R
    JAMA Intern Med; 2022 Feb; 182(2):165-171. PubMed ID: 34928302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world Impact of 2-dose SARS-CoV-2 Vaccination in Kidney Transplant Recipients.
    McEvoy CM; Lee A; Misra PS; Lebovic G; Wald R; Yuen DA
    Transplantation; 2022 May; 106(5):e279-e280. PubMed ID: 35220385
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the Correlation Between Responders and Non-Responders to the Second Coronavirus Disease Vaccination In Kidney Transplant Recipients: A Retrospective Single-Center Cohort Study.
    Matsunami M; Suzuki T; Sugihara S; Toishi T; Nagaoka K; Fukuda J; Ohara M; Takanashi Y; Ochi A; Yashima J; Kuji H; Matsue K
    Transplant Proc; 2022; 54(6):1483-1488. PubMed ID: 35868872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients.
    Schimpf J; Davidovic T; Abbassi-Nik A; Sprenger-Mähr H; Lhotta K; Zitt E
    Transpl Int; 2022; 36():10357. PubMed ID: 35391899
    [No Abstract]   [Full Text] [Related]  

  • 10. The type of SARS-CoV-2 vaccine influences serological response in kidney transplant recipients.
    Correia AL; Leal R; Pimenta AC; Fernandes M; Guedes Marques M; Rodrigues L; Santos L; Romãozinho C; Sá H; Pratas J; Araújo L; Figueiredo A; Alves R
    Clin Transplant; 2022 Apr; 36(4):e14585. PubMed ID: 34997797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody Response to SARS-CoV-2 mRNA Vaccine Among Kidney Transplant Recipients.
    Mungmunpuntipantip R; Wiwanitkit V
    Exp Clin Transplant; 2022 Nov; 20(11):1048. PubMed ID: 36524892
    [No Abstract]   [Full Text] [Related]  

  • 12. Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients.
    Al Jurdi A; Gassen RB; Borges TJ; Lape IT; Morena L; Efe O; Solhjou Z; El Fekih R; Deban C; Bohan B; Pattanayak V; Kotton CN; Azzi JR; Riella LV
    Kidney Int; 2022 Jun; 101(6):1282-1286. PubMed ID: 35429496
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunologic response to SARS-CoV-2 mRNA vaccination in pediatric kidney transplant recipients.
    Kermond RF; Ozimek-Kulik JE; Kim S; Alexander SI; Hahn D; Kesson A; Wood N; McCarthy HJ; Durkan AM
    Pediatr Nephrol; 2023 Mar; 38(3):859-866. PubMed ID: 35833990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of SARS-CoV-2 Vaccine in Kidney Transplant Recipients: A Cross-Sectional Study in Korea.
    Song SH; Chung KY; Jee Y; Chung HS; Kim K; Minn D; Kim SK
    J Korean Med Sci; 2023 Feb; 38(5):e22. PubMed ID: 36747360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fourth dose of the SARS-CoV-2 vaccine in kidney transplant recipients with previously impaired humoral antibody response.
    Midtvedt K; Vaage JT; Heldal K; Munthe LA; Lund-Johansen F; Åsberg A
    Am J Transplant; 2022 Nov; 22(11):2704-2706. PubMed ID: 35533010
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluating the antibody response to SARS-COV-2 vaccination amongst kidney transplant recipients at a single nephrology centre.
    Chukwu CA; Mahmood K; Elmakki S; Gorton J; Kalra PA; Poulikakos D; Middleton R
    PLoS One; 2022; 17(3):e0265130. PubMed ID: 35271655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of anti-SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients.
    Bertrand D; Laurent C; Lemée V; Lebourg L; Hanoy M; Le Roy F; Nezam D; Pruteanu D; Grange S; de Nattes T; Lemoine M; Candon S; Guerrot D
    Kidney Int; 2022 Aug; 102(2):440-442. PubMed ID: 35618097
    [No Abstract]   [Full Text] [Related]  

  • 18. Serological findings following the second and third SARS-CoV-2 vaccines in lung transplant recipients.
    Bárczi E; Varga V; Nagy A; Eszes N; Jáky-Kováts Z; Müller V; Bohács A
    Immun Inflamm Dis; 2022 Aug; 10(8):e646. PubMed ID: 35894705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.
    Benotmane I; Gautier-Vargas G; Cognard N; Olagne J; Heibel F; Braun-Parvez L; Martzloff J; Perrin P; Moulin B; Fafi-Kremer S; Caillard S
    Kidney Int; 2021 Jun; 99(6):1487-1489. PubMed ID: 33775674
    [No Abstract]   [Full Text] [Related]  

  • 20. Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients.
    Hoffman TW; Meek B; Rijkers GT; van Kessel DA
    Transpl Immunol; 2022 Jun; 72():101599. PubMed ID: 35390480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.